Skip to main content
OpenTrials

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,254 public trials 565 recruiting studies
Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Active, Not Recruiting

Abemaciclib and Letrozole to Treat Endometrial Cancer

NCT04393285

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of South Alabama Mitchell Cancer Center Mobile, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Smillow Cancer Care at Greenwich Greenwich, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Predictive Assays In Cervix Cancer

NCT01181375

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT05081609

Conditions
2L+ Cervical Cancer, Advanced Solid Tumor, Female Urogenital Diseases, +27 more
Locations
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Springfield, Illinois, United States
  • Ascendis Pharma Investigational Site Louisville, Kentucky, United States
View all 68 locations
View Trial Details

Related conditions